OPKO Health, Inc. Payments for Repurchase of Redeemable Preferred Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- OPKO Health, Inc. payments for repurchase of redeemable preferred stock for the quarter ending 2011-12-31 was $0.00.
- OPKO Health, Inc. payments for repurchase of redeemable preferred stock for the quarter ending 2011-09-30 was $0.00.
- OPKO Health, Inc. payments for repurchase of redeemable preferred stock for fiscal 2013 was $0.00.
- OPKO Health, Inc. payments for repurchase of redeemable preferred stock for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- OPKO Health, Inc. payments for repurchase of redeemable preferred stock for fiscal 2011 was $1.79M.
| Period end | Payments for Repurchase of Redeemable Preferred Stock 3 month | Payments for Repurchase of Redeemable Preferred Stock 12 month |
|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-03 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-03 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.79M 10-K · filed 2014-03-03 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |